Leproust Emily M. sold $2.5M of TWST
Leproust Emily M. (Chief Executive Officer) sold 19,952 shares of Twist Bioscience Corp (TWST) at $125.08 ($2.50M total) on 2026-08-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider selling activity, but the text provides no new company performance, guidance, or regulatory developments.
Market read
Traders may note the insider sale size and timing, but there is no fundamental catalyst in the filing excerpt.
What to watch
The article does not state whether the CEO’s remaining holdings changed materially versus prior plans, nor does it provide context on total planned sales.
Background
This is an SEC Form 4 insider transaction disclosure for Twist Bioscience.
Ticker impact
Twist Bioscience CEO Leproust sold 19,952 shares in an open-market transaction for about $2.50M under a 10b5-1 plan.
Likely limited immediate impact; any reaction should be small and short-lived unless accompanied by other news.
Form 4 shows a pre-arranged 10b5-1 open-market sale with no accompanying operational or financial guidance changes in the text.
Market effects
No sector read-through is provided beyond a single insider sale.
None indicated.
None indicated.
Counterpoint
Insider sales under 10b5-1 can be purely mechanical and may not signal reduced confidence.
Key entities
- issuerTwist Bioscience Corp
Subject of the Form 4 insider sale by its CEO.
- insiderEmily M. Leproust
CEO and officer/director who sold shares under a 10b5-1 plan.
